Keyphrases
Adjunctive Therapy
11%
Antifungal Targets
22%
Aspergillus Fumigatus
100%
Attenuated Virulence
11%
Caenorhabditis Elegans
11%
Cell Wall
22%
Cell Wall Biogenesis
100%
Cell Wall Biosynthesis
22%
Fructose
11%
Fumigatus
44%
Fungal Cell Wall
11%
Fungal Cells
11%
Fungal Survival
11%
Galleria Mellonella Model
11%
Glucan
11%
Glucose-6-phosphatase (G6Pase)
100%
Glycolysis
11%
Glycolysis Pathway
11%
Glycolytic Enzymes
11%
Growth Conditions
11%
Hypoxia-related Diseases
11%
Infections In Immunocompromised Hosts
11%
Metabolic Regulation
11%
Opportunistic Fungal Pathogen
22%
Optimized Growth
11%
Pentose Phosphate Pathway
11%
Pleiotropic Effects
11%
Putative Drug Targets
11%
Retarded Development
11%
Sugar Phosphate
11%
Systemic Antifungals
11%
Therapeutic Target
11%
Virulence
11%
Wall Defects
11%
Immunology and Microbiology
Aspergillus fumigatus
100%
Biogenesis
100%
Caenorhabditis Elegans
12%
Cell Wall
100%
Crystal Structure
25%
Fungal Cell Wall
12%
Galleria mellonella
12%
Glucose 6 Phosphate Isomerase
100%
Hexose Monophosphate Shunt
12%
Immunocompromised Patient
12%
Infectious Agent
25%
Metabolic Regulation
12%
Pentose Phosphate Cycle
12%
Precursor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Antifungal Agent
37%
Aspergillus fumigatus
100%
Caenorhabditis Elegans
12%
Disease
12%
Fructose
12%
Fructose 6 Phosphate
12%
Galleria mellonella
12%
Glucan
12%
Glucose 6 Phosphate
12%
Glucose 6 Phosphate Isomerase
100%
Glycolytic Enzyme
12%
Hypoxia
12%
Immunocompromised Patient
12%
Infection
25%
Infectious Agent
25%
Pentose Phosphate
12%